Emerging from the UK, retatrutide, a novel molecule, is sparking considerable excitement within the medical community regarding its ability for weight control . This dual GIP and GLP-1 receptor agonist looks to provide a substantial benefit over existing therapies, showing encouraging results in preliminary clinical studies . Researchers think its